INS and metabolic disease: Hsu et al. had indicated that arecoline led to the development of insulin resistance and metabolic diseases by inhibiting adipogenic differentiation such as inducing adenylyl cyclase-dependent lipolysis and interfering insulin-induced glucose uptake[32].